Dechra Pharmaceuticals : 17 October 2023 Annual Report 2023 ESEF XHTML

Dechra Pharmaceuticals PLCAnnual Report and Accounts for the year ended 30 June 2023 www.dechra.com

96

Senior

Executive Team

Giles Coley

Dechra Veterinary Products

International Group Director

Background:

Giles joined Dechra in January

1999 as sales and marketing

manager for Arnolds Veterinary

Products, having previously spent

14 years primarily involved in dairy

farming business consultancy.

During his time at Dechra he

has been responsible for the

launch and market development

of a number of our key brands,

including Vetoryl. Giles has also

been an integral member of the

teams that ensured fast and

smooth integrations of several of

our acquisitions, and in particular

as lead in the integration of Apex

in 2016 and Venco in 2019.

In his role of Dechra Veterinary

Products International Group

Director, his responsibilities are

extremely varied and involve

managing and growing our

existing business through APAC

and South American business

and distribution partners, as

well as further developing our

Dechra International strategy

through product registrations

and market development. Giles

has a BSc degree in Agricultural

Technology.

Giles is located in Sansaw, UK.

Pets:

Mike Eldred

President North America

Background:

Mike joined Dechra in 2004

and is responsible for Dechra

Veterinary Products' North

American business. Mike has

more than 25 years' experience

in the animal health sector,

having held senior positions in

business development, sales and

operations at Virbac Corporation,

Fort Dodge Animal Health and

Sanofi Animal Health. As our

first employee in the USA, he

has built the North American

commercial team to greater than

250 employees and $400 million

in revenue. Mike has also been

involved in several commercial

agreements and acquisitions for

the Group including Pharmaderm,

DermaPet, Putney, Ampharmco

and Med-Pharmex. Mike has a BA

and MBA in Business.

Mike is located in Overland Park,

Kansas, USA.

Pets:

Katy Clough

Chief People Officer

Background:

Katy joined Dechra in April 2014

from AppSense Ltd where she

was the Vice President of HR

Europe and Rest of the World.

With over 15 years' experience

operating at Director level

within Software, Health, Travel

and Finance industries, Katy

brings with her a wealth of HR

expertise gained in both blue

chip corporates and smaller

entrepreneurial companies.

She has strong international,

leadership and M&A experience

and has taken responsibility for

driving the global people agenda

for the Dechra Group.

Katy is located at Head Office,

Northwich, UK.

Pets:

Melanie Hall

Company Secretary

Committee Membership:

Disclosure.

Background:

Melanie joined Dechra in

January 2010 as the Assistant

Company Secretary, and was

promoted to Deputy Company

Secretary in May 2015, and

Company Secretary in July 2017.

Prior to joining Dechra, she has

gained over 25 years' experience

in various company secretarial

roles including at GKN plc, TRW

Automotive Inc and Pendragon

PLC. Melanie is a Fellow of the

Chartered Governance Institute.

Melanie is responsible for the

Company Secretarial, Compliance

and Legal team.

Melanie is located at Head Office

in Northwich, UK.

Pets:

Milton McCann

Group Manufacturing and

Supply Director

Background:

Milton was appointed as Group

Manufacturing & Supply Director

on 1 April 2021, following 11 months

as Interim Group Manufacturing

& Supply Director. He joined

Dechra in January 2016 as Group

Manufacturing Finance Director. In

February 2019, he was the Interim

Site Director at our Skipton Facility

until being appointed as Group

Supply Chain and Procurement

Director, Dechra Pharmaceuticals

Manufacturing & Supply in October

2019.

Before joining Dechra, Milton

had senior financial roles in

different manufacturing industries

including coatings, adhesives and

chemicals. Just prior to joining

Dechra he worked for Aramark

in the food and facilities services

sector.

Milton is responsible for our

internal sites in Europe and USA,

and external manufacturing sites

globally.

Milton is located at Head Office

in Northwich, UK.

Pets:

None

Patrick Meeus

Chief Scientific Officer

Background:

Patrick joined Dechra in July 2022

and has over 30 years' experience

in animal health covering vaccine,

small molecule and diagnostics

product development across

all animal species. He also

brings substantial international

experience having lived and

worked in academia and industry

on four different continents. In

2004 Patrick joined Pfizer Animal

Health, now Zoetis, where he led

a wide range of teams, projects

and strategic initiatives from

early discovery through product

development and launch. He

joined Elanco in 2018 as the

Senior/Executive Director of

Companion Animal Product

Development.

Patrick has a Veterinary Degree

from the University of Gent

(Belgium), a PhD in Infectious

Diseases from the University of

Florida (USA) and was a founding

Diplomate of both the European

Veterinary Parasitology College

and the American College of

Veterinary Microbiologists-

Parasitology.

Patrick is currently based in Basel,

Switzerland.

Pets:

Jamie Adams*

Chief Information Officer

Background:

Jamie joined Dechra in June 2022

as Chief Information Officer. Prior

to joining, he held the same role

for Scapa plc, a global healthcare

and industrial products group

and has gained over 25

years' experience in various IT

leadership roles in large scale

pharmaceutical & medical device

organisations including Smith &

Nephew and AstraZeneca.

Jamie leads the global IT team

and is responsible for IT Strategy

development and execution,

including all IT change &

innovation activity as well as core

IT service provision. He has an

MBA from Durham University and

a BSc (Hons) degree in Business &

IT from Northumbria University.

He is located at Head Office,

Northwich, UK.

Pets:

* Appointed to the SET on 1 July 2023.

The Senior Executive Team

(SET) was established

in 2013 to lead the

development and

implementation of the

business strategy. The

SET is led by the Chief

Executive Officer and is

comprised of the three

Executive Directors and

the Business Directors

responsible for leading

each of the Group's

key functions. The SET

is scheduled to meet

formally four times

a year to discuss the

implementation of the

strategy, share best

practice and provide

updates on their business

or function as well as

sharing market trends

which impact the

business.